Quality of Life Assessment in Patients with Multiple Sclerosis Receiving Interferon Beta-1a: A Comparative Longitudinal Study of Avonex and Its Biosimilar CinnoVex

Table 2

Factors affecting physical health scores of the studied patients.

Factor		Avonex			CinnoVex
	Baseline	Stages 2–4	𝑃 value	Baseline	Stages 2–4	𝑃 value
Physical health	12.8	13.1	0.587	12.2	12.4	0.475
Health perception	9.9	10.1	0.559	9.9	9.4	0.127
Energy/fatigue	6.2	5.9	0.185	5.7	5.8	0.541
Role limitations due to physical problems	7.6	7.4	0.914	6.3	6.3	0.958
Pain	7.6	7.8	0.640	7.5	7.4	0.185
Sexual function	1.7	1.9	0.411	2.6	2.8	0.585
Social function	8.2	8.5	0.516	8.3	8.3	0.877
Physical health distress	7.4	7.3	0.757	6.9	7.0	0.685
Physical health composite	61.8	63.1	0.677	59.8	59.8	0.884